Tahir Amin
banner
tahiramin.bsky.social
Tahir Amin
@tahiramin.bsky.social
CEO @imakglobal.bsky.social. Renegade IP lawyer. Critically rethinking IP laws through (neo)colonial/neoliberal systems of power, and that empty word “innovation”.
Hyaluronidase (the ingredient Merck added to create the SC version of Keytruda) has been used by plenty of other companies to enable SC delivery. It’s not exactly something that wasn’t known…
October 13, 2025 at 11:01 PM
In a recent FTC listening session, Hans Sauer of BIO suggested that pharma execs don’t coordinate with lawyers to strategically use patents to block competition. I guess he forgot about the Congressional investigation exposing how AbbVie hired McKinsey to do exactly that.
July 23, 2025 at 9:42 PM
Thank you to The Plus SideZ podcast for having me on to talk about the patent system and how the pharma industry’s abuse of it keeps GLP-1 prices so high.
July 16, 2025 at 5:28 PM
The shadow org flunked Senators Peter Welch and Maggie Hassan. Probably bc they’ve been grilling pharma CEOs in Congressional hearings and trying to close loopholes in the patent system that the pharma industry currently exploits to jack up drug prices.
June 25, 2025 at 5:05 PM